Sterling Pharma Solutions
Andrew Henderson is the current Chief Operating Officer, Chief Integration Officer, and Chief Commercial Officer at Sterling Pharma Solutions since July 2015. Prior to that, Andrew held roles such as Corporate Development Director and Key Account Director at Aesica Pharmaceuticals Ltd from August 2010 to June 2015. Before that, Andrew worked at Onyx Scientific as a Business Development Manager and Chemist from May 2006 to July 2010. Andrew holds a BSc in Chemistry from the University of Leeds, a PhD in Organic Chemistry from Newcastle University, and has completed a Finance for Senior Executives program at Harvard Business School in September 2023.
This person is not in any offices
Sterling Pharma Solutions
1 followers
Sterling Pharma Solutions has over 50 years' experience serving the global pharmaceutical industry. Our facilities are located in Cramlington and Newcastle Biosphere, UK; Deeside, Wales; Cork, Ireland, as well as North Carolina and Wisconsin in the US. Our state-of-the-art facilities, proprietary technologies and experienced people are among the best in the industry. We have a proven track record in the supply of chemistry and analytical services across the entire product lifecycle, from grams to tonnes, from pre-clinical to commercial supply. Our world-class safety and quality standards are globally recognised and demonstrated through successful MHRA and FDA inspections and CIA Gold Awards for Safety the last three consecutive years. We pride ourselves on our customer focus and service approach, offering flexible, tailored solutions to our customers. In addition, our North Carolina and Newcastle Biosphere facilities offer expert chemistry solutions for small volume batches or products in the early stages of clinical trials. Our Deeside, Wales facility provide bioconjugation development services and specialised in antibody drug conjugation (ADC) research and development. Find out more: www.sterlingpharmasolutions.com/sterling-facilities